

NCT03333655 Raw comparison:

Summary:
CHIA has 4 criteria while your personal folder has 7 criteria
Total found criteria: 2/4
Total not Found: 2/4
Total Extra: 3
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Response assessment of complete response (CR)      │ Response assessment of complete response (CR)      │
│ partial response (PR) long stable disease (SD) for │ partial response (PR) or long-term stable disease  │
│ >3 months with a cancer immunotherapy treatment    │ (SD) for \>6 months with a cancer immunotherapy    │
│ for metastatic cancer or hematologic malignancies  │ treatment for metastatic cancer or hematologic     │
│ either through a marketed CPI or through           │ malignancies either through a marketed CPI or      │
│ participation in a Roche/Genentech CPI clinical    │ through participation in a Roche/Genentech CPI     │
│ trial                                              │ clinical trial                                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant lactating or intending to become pregnant │ Pregnant lactating or intending to become pregnant │
│ during the study                                   │ during the study                                   │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                     │
╞═════════════════════════════════════════════════════════════════════════════════════════╡
│ Availability of tumor biopsy material extracted and preserved by the investigating site │
├─────────────────────────────────────────────────────────────────────────────────────────┤
│ Participants taking CPI combination therapies with chemotherapy are not permitted       │
╘═════════════════════════════════════════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                              │
╞══════════════════════════════════════════════════════════════════════════════════════╡
│ Must have minimum age of 18 Years                                                    │
├──────────────────────────────────────────────────────────────────────────────────────┤
│ Participants receiving CPI treatment as part of a non-Roche/Genentech clinical trial │
├──────────────────────────────────────────────────────────────────────────────────────┤
│ Availability of tissue sample                                                        │
╘══════════════════════════════════════════════════════════════════════════════════════╛